Virgil A. S. H. Dalm

Also affiliated with Erasmus University Rotterdam

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome”.

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood(2022)10.1182/blood.2022018546

N/A

3.2DataRank · unranked

132 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +17 more

Interim analysis: Open-label extension study of leniolisib for patients with APDS

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.09.032

N/A

1.2DataRank · unranked

40 citations

Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +15 more

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Blood Advances(2024)10.1182/bloodadvances.2023011000

N/A

0.637DataRank · unranked

15 citations

Elaine Kulm, Jennifer Grossman, David Buchbinder, Hey Chong, Jason Bradt +5 more

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clinical Immunology(2024)10.1016/j.clim.2024.110400

N/A

0.434DataRank · unranked

17 citations

Anna Šedivá, Virgil A. S. H. Dalm, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +14 more

“Deficiency in ELF4, X-Linked”: a Monogenic Disease Entity Resembling Behçet’s Syndrome and Inflammatory Bowel Disease

Journal of Clinical Immunology(2024)10.1007/s10875-023-01610-8

N/A

0DataRank · unranked

15 citations

Shannon K. O’Connor, Marat Kribis, Molly L. Bucklin, Dinesh Babu Uthaya Kumar, Paul Tyler +25 more

Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation

Nature Immunology(2021)10.1038/s41590-021-00984-4

N/A

0DataRank · unranked

108 citations

Molly L. Bucklin, Mengting Zhao, Timothy J. Maher, Andrew J. Rice, Weizhen Ji +13 more

Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study

Future Rare Diseases(2024)10.1080/23995270.2024.2379239

N/A

0DataRank · unranked

0 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon +6 more

Clinical and In Vitro Evidence Favoring Immunoglobulin Treatment of a Chronic Norovirus Infection in a Patient With Common Variable Immunodeficiency

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac085

N/A

0DataRank · unranked

34 citations

Virgil A. S. H. Dalm, Pieter L. A. Fraaij, Bas B. Oude Munnink, Claudia M. E. Schapendonk, Ray Izquierdo-Lara +6 more

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

iScience(2022)10.1016/j.isci.2022.105753

N/A

0DataRank · unranked

12 citations

Roos S. G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J. R. Rietdijk, Katharina S. Schmitz +19 more

Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination

medRxiv(2022)10.1101/2022.07.15.22277639

N/A

0DataRank · unranked

2 citations

Roos S. G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J. R. Rietdijk, Katharina S. Schmitz +19 more